Vitamin D During In Vitro Fertilisation (IVF) - A Prospective Randomized Trial
Phase 3
- Conditions
- Pregnancy Complication
- Registration Number
- NCT01019785
- Lead Sponsor
- Karolinska University Hospital
- Brief Summary
During IVF treatment women will be randomized into supplementation with a high or a low dose of Vitamin D Main outcome Laboratory pregnancy, live pregnancy at 12 weeks, Baby take home rate, OHSS Secondary outcome: 1. Pregnancy complications (pregnancy hypertension, SGA, Diabetes) 2.Thrombin generation
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 1000
Inclusion Criteria
- All women initiating IVF treatment
Exclusion Criteria
- Women that have entered the study before
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Laboratory pregnancy, live pregnancy at 12 weeks, take home baby rate 4 weeks to 9 month
- Secondary Outcome Measures
Name Time Method Pregnancy complications (pregnancy hypertension, SGA, diabetes) 9 months
Trial Locations
- Locations (1)
IVF Unit Karolinska University Hospital, Huddinge
🇸🇪Huddinge, Sweden
IVF Unit Karolinska University Hospital, Huddinge🇸🇪Huddinge, Sweden